Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with l-NAME-induced hypertension

Zhou, 2004, Nitric oxide, angiotensin II, and hypertension, Semin Nephrol, 24, 366, 10.1016/j.semnephrol.2004.04.008 Koyanagi, 2000, Role of transforming growth factor-beta1 in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis, Hypertension, 35, 86, 10.1161/01.HYP.35.1.86 Sharifi, 2005, Investigation of local ACE activity and structural alterations during development of l-NAME-induced hypertension, Pharmacol Res, 52, 438, 10.1016/j.phrs.2005.07.004 Pereira, 2004, Enalapril attenuates cardiorenal damage in nitric-oxide-deficient spontaneously hypertensive rats, Clin Sci (Lond), 106, 337, 10.1042/CS20030268 Katoh, 2000, Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis, J Mol Cell Cardiol, 32, 73, 10.1006/jmcc.1999.1053 Zhang, 2003, Soy food consumption is associated with lower risk of coronary heart disease in Chinese women, J Nutr, 133, 2874, 10.1093/jn/133.9.2874 Chen, 2006, Effects of various soya protein hydrolysates on lipid profile, blood pressure and renal function in five-sixths nephrectomized rats, Br J Nutr, 96, 435 Matsui, 2000, Depressor effect of wheat germ hydrolysate and its novel angiotensin I-converting enzyme inhibitory peptide, Ile-Val-Tyr, and the metabolism in rat and human plasma, Biol Pharm Bull, 23, 427, 10.1248/bpb.23.427 Mallikarjun Gouda, 2006, Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max), J Agric Food Chem, 54, 4568, 10.1021/jf060264q Yang, 2004, Soyabean protein hydrolysate prevents the development of hypertension in spontaneously hypertensive rats, Br J Nutr, 92, 507, 10.1079/BJN20041218 Graciano, 2004, Intrarenal renin–angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis, J Am Soc Nephrol, 15, 1805, 10.1097/01.ASN.0000131528.00773.A9 Hernandez-Ledesma, 2003, Assessment of the spectrophotometric method for determination of angiotensin-converting-enzyme activity, influence of the inhibition type, J Agric Food Chem, 51, 4175, 10.1021/jf034148o Miranda, 2001, A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite, Nitric Oxide, 5, 62, 10.1006/niox.2000.0319 Aebi, 1984, Catalase in vitro, Methods Enzymol, 105, 121, 10.1016/S0076-6879(84)05016-3 Griesmacher, 1995, Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus, Am J Med, 98, 469, 10.1016/S0002-9343(99)80347-7 Raij, 2001, Workshop: hypertension and cardiovascular risk factors: role of the angiotensin II–nitric oxide interaction, Hypertension, 37, 767, 10.1161/01.HYP.37.2.767 Ono, 1999, Apoptosis, coronary arterial remodeling, and myocardial infarction after nitric oxide inhibition in SHR, Hypertension, 34, 609, 10.1161/01.HYP.34.4.609 Ceconi, 2007, ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT, Cardiovasc Res, 73, 237, 10.1016/j.cardiores.2006.10.021 De Gennaro Colonna, 2005, Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in l-NAME-induced hypertensive rats, Eur J Pharmacol, 516, 253, 10.1016/j.ejphar.2005.04.004 Khattab, 2005, Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat, Kidney Blood Press Res, 28, 243, 10.1159/000088829 Kim, 2000, Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases, Pharmacol Rev, 52, 11 Suda, 2004, Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin–angiotensin system and oxidative stress, Arterioscler Thromb Vasc Biol, 24, 1682, 10.1161/01.ATV.0000136656.26019.6e Minamino, 2000, Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats, Cardiovasc Drugs Ther, 14, 533, 10.1023/A:1007897308187 Takemoto, 1997, Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis, Hypertension, 30, 1621, 10.1161/01.HYP.30.6.1621 Katoh, 1998, Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats, Circ Res, 83, 743, 10.1161/01.RES.83.7.743 McFarlane, 2003, Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease, Am J Cardiol, 91, 30H, 10.1016/S0002-9149(03)00432-6 Heneman, 2007, Soy protein with and without isoflavones fails to substantially increase postprandial antioxidant capacity, J Nutr Biochem, 18, 46, 10.1016/j.jnutbio.2006.03.001 Flesch, 2003, Activation and functional significance of the renin–angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor, Circulation, 108, 598, 10.1161/01.CIR.0000081768.13378.BF Pandolfi, 2001, Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects, Arterioscler Thromb Vasc Biol, 21, 1378, 10.1161/hq0801.093667 Thogersen, 1998, High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor, Circulation, 98, 2241, 10.1161/01.CIR.98.21.2241 Brown, 2006, Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition, Hypertension, 47, 441, 10.1161/01.HYP.0000202478.79587.1a Kaikita, 2001, Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition, Circulation, 104, 839, 10.1161/hc3301.092803 Garcia-Estan, 2006, Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats, Clin Sci (Lond), 110, 227, 10.1042/CS20050165 Shin, 2001, His-His-Leu, an angiotensin I converting enzyme inhibitory peptide derived from Korean soybean paste, exerts antihypertensive activity in vivo, J Agric Food Chem, 49, 3004, 10.1021/jf001135r Saito, 1994, Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees, Biosci Biotechnol Biochem, 58, 1767, 10.1271/bbb.58.1767 Lo, 2005, Angiotensin I converting enzyme inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein, J Agric Food Chem, 53, 3369, 10.1021/jf048174d Chen, 2003, Identification of angiotensin I-converting enzyme inhibitory peptides derived from the peptic digest of soybean protein, J food Biochem, 26, 543, 10.1111/j.1745-4514.2002.tb00772.x